DNMR - Danimer Scientific, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 306.83M
Enterprise value 610.42M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)6.05
Price/book (mrq)0.86
Enterprise value/revenue 12.11
Enterprise value/EBITDA -5.98

Trading information

Stock price history

Beta (5Y monthly) 1.49
52-week change 3-22.52%
S&P500 52-week change 33.90%
52-week high 35.9200
52-week low 31.5700
50-day moving average 33.3164
200-day moving average 32.8265

Share statistics

Avg vol (3-month) 31.3M
Avg vol (10-day) 3815.47k
Shares outstanding 5101.94M
Implied shares outstanding 6N/A
Float 890.03M
% held by insiders 18.11%
% held by institutions 141.06%
Shares short (14 May 2023) 415.36M
Short ratio (14 May 2023) 414.63
Short % of float (14 May 2023) 417.16%
Short % of shares outstanding (14 May 2023) 415.07%
Shares short (prior month 13 Apr 2023) 415.79M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 0.00%
Operating margin (ttm)-248.63%

Management effectiveness

Return on assets (ttm)-9.85%
Return on equity (ttm)-45.05%

Income statement

Revenue (ttm)50.4M
Revenue per share (ttm)0.50
Quarterly revenue growth (yoy)-19.10%
Gross profit (ttm)N/A
EBITDA -101.54M
Net income avi to common (ttm)-190.01M
Diluted EPS (ttm)-1.8300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)101.99M
Total cash per share (mrq)1
Total debt (mrq)405.58M
Total debt/equity (mrq)114.05
Current ratio (mrq)7.22
Book value per share (mrq)3.49

Cash flow statement

Operating cash flow (ttm)-50.1M
Levered free cash flow (ttm)-155.22M